Abstract
Objective: This study was conducted to evaluate the association between dyspnea severity, COVID-19 fear, and death anxiety levels in individuals diagnosed with chronic obstructive pulmonary disease (COPD). Material and Methods: This descriptive relationshipseeking study was conducted with 144 patients aged 40 years and older who were admitted to a state hospital emergency department with a diagnosis of COPD. The data were collected using a personal information form, the Medical Research Council (MRC) dyspnea scale, COPD assessment Test-CAT, Death Anxiety Scale (DAS), and Coronavirus Fear Scale (FCV-19S). Results: The mean age of the individuals was 66.39 ± 9.72. The fear of death was severe in 52 patients (36.1%) and mild in 48 patients (33.3%). The difference between DAS and FCV-19S was statistically significant according to the severity of COPD, frequency of admission to hospital, presence of other chronic diseases, ability to meet physical needs, diagnosis of COVID-19, and anxiety levels related to COVID-19 transmission (p<0.05). DAS and FCV-19S increased in accordance with the severity of dyspnea. As the level of death anxiety increased from mild to severe, the mean score of the FCV-19S increased accordingly. Conclusion: The majority of COPD patients (69.4%) experience moderate or higher fear of death and their COVID-19 fear levels are at high levels. COPD patients with severe dyspnea, female patients, and those with additional chronic diseases should be evaluated in terms of death anxiety and fear of COVID-19. Additionally, they should be provided with the necessary psychological support.

This publication has 13 references indexed in Scilit: